Back to search
Subjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Subjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Subjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA) trials you may qualify forThis study is designed to compare the treatment effect of PEGPH20 combined with nab-paclitaxel (NAB) and gemcitabine (GEM) \[PAG\] to NAB and GEM \[AG\] in part…
The purpose of this study is to compare the efficacy and safety of PEGylated Recombinant Human Hyaluronidase (PEGPH20) combined with nab-paclitaxel plus gemcita…
This is a Phase I safety and feasibility study. Subjects will be enrolled serially. For subject safety, the preceding subject must have completed one cycle of t…